We have a 70% complete response rate in patients who failed othertherapies, so our Phase II data, which is in the public domain, shows about 128 patients with an average complete response of about 70%.
..........
3) Complete all DMC ( Data Monitoring Committees) Meetings POSITIV :
Since commencement, nine meetings of the independent DMC have recommended to “continue the trial unmodified”
The DMC is an independent group that acts in an advisory capacity to the Company.Its role is to evaluate the progress of the clinical trial,including monitoring the safety and efficacy data generated in the trial.
..........
4) 21 New Employees since Feb 2010 up from 190 to 211 Personnel :
September 10, The fully-integrated company employs 211 skilled personnel and has three operating divisions: Human Health, Animal Health, and Food Safety
10/02/10 The fully-integrated company employs approximately 190 skilled personnel and has three operating divisions: Human Health, Animal Health, and Food Safety.
..........
5) Positive Comments by CEO , BladderCancer Forum and Alvaro Morales ( Father of BCG )
Dr Morales, professor of urology and oncologyat Queen’s University, Kingston, Ont., and principal investigator ofthe trial: “My own experience suggests very strongly that the safety profile of MCC is much better than BCG and,certainly, MCC is easier to handle, from the pharmacist’s,nurse’s and physician’s points of view,due to the risk of acquiring a serious infection fromimproper handling of BCG,which is a live bacteria,as opposed to MCC that contains only bacterial cell wall fragments and DNA.”Dr. Morales is editorof The Chronicle of Urology &Sexual Medicine.
........
6) Early (5 months) Exercise of option to take the World Wide Rights for Urocidin by Endo Pharma !
Bioniche Life Sciences Inc. (BNC) Achieves Two Additional Milestones Under Licensing Agreement; Endo Pharmaceuticals (ENDP) Takes up Global Rights; Bioniche to Get $8 Million 2/12/2010
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.